Biophytis SA

ALBPS

Company Profile

  • Business description

    Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

  • Contact

    BC 9, Batiment A 4eme etage
    4 pace Jussieu
    Sorbonne University
    Paris75005
    FRA

    T: +33 144272300

    https://www.biophytis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    24

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.7048.800.56%
CAC 407,901.4422.980.29%
DAX 4024,562.6313.070.05%
Dow JONES (US)44,458.30217.540.49%
FTSE 1008,945.4478.420.88%
HKSE24,028.37136.050.57%
NASDAQ20,611.34192.870.94%
Nikkei 22539,646.36174.92-0.44%
NZX 50 Index12,760.208.41-0.07%
S&P 5006,263.260.000.00%
S&P/ASX 2008,589.2050.600.59%
SSE Composite Index3,509.6816.630.48%

Market Movers